Wang C.-H.Li S.-T.Lin T.-L.Cheng Y.-Y.Sun T.-H.JIN-TOWN WANGCheng T.-J.R.Mong K.K.T.Wong C.-H.Wu C.-Y.2019-09-022019-09-0220131433-7851https://www.scopus.com/inward/record.uri?eid=2-s2.0-84883010128&doi=10.1002%2fanie.201302540&partnerID=40&md5=ab0cdc3d7380324fb19ffcaf8607199ahttps://scholars.lib.ntu.edu.tw/handle/123456789/417151Sweetening the deal: N.meningitidis serogroup W135 capsular oligosaccharides were synthesized in lengths from disaccharides to decasaccharides. Sera from mice immunized with these oligosaccharide-protein conjugates were examined by a glycan microarray (see picture) and bactericidal assay for antibody specificity and the ability to kill bacteria. Copyright ? 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.en-USbactericidal; N. meningitidis; oligosaccharides; total synthesis; vaccine[SDGs]SDG3bactericidal; Glycan microarrays; Immunogenicity; Meningitidis; Neisseria meningitidis; Total synthesis; Vaccine development; Vaccines; Oligosaccharides; oligosaccharide; recombinant vaccine; vaccine; article; bactericidal; chemical structure; chemistry; immunology; N. meningitidis; Neisseria meningitidis; synthesis; total synthesis; bactericidal; N. meningitidis; oligosaccharides; total synthesis; vaccine; Molecular Structure; Neisseria meningitidis, Serogroup W-135; Oligosaccharides; Vaccines, Syntheticjournal article10.1002/anie.201302540238433132-s2.0-84883010128